SCHEMBL4973208

SCHEMBL4973208

CC(c1ccccc1)C1(C(=O)O)CCC1NC(N)=O

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
LMNA P02545 3/20 0.37
EPHX1 P07099 2/20 0.37
HPGD P15428 2/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C19 P33261 1/20 0.37
RAB9A P51151 1/20 0.37
KCNQ3 O43525 1/20 0.37
KCNQ2 O43526 1/20 0.37
KCNQ4 P56696 1/20 0.37
KCNQ5 Q9NR82 1/20 0.37
RECQL P46063 1/20 0.37
GRM7 Q14831 2/20 0.36
TACR1 P25103 1/20 0.36
NR3C2 P08235 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ALOX5 P09917 1/20 0.35
NR5A2 O00482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4560516 0.72 KCNQ3 (0.38) KMT2ALMNAHPGDKCNQ3KCNQ2
SCHEMBL4862021 0.69 KMT2A (0.39) MEN1KMT2ALMNAEPHX1HPGD
SCHEMBL28046467 0.68 ALOX5 (0.40) KMT2ALMNAEPHX1HPGDCYP3A4
SCHEMBL4973221 0.67 RECQL (0.38) MEN1KMT2ALMNAEPHX1HPGD
SCHEMBL4558507 0.67 KCNQ3 (0.40) MEN1KMT2ALMNAEPHX1HPGD
SCHEMBL28318116 0.66 ALOX5 (0.44) KMT2ALMNAHPGDALOX5
SCHEMBL27932361 0.66 ALOX5 (0.44) KMT2ALMNAHPGDALOX5
SCHEMBL4558684 0.66 KDM1A (0.42) EPHX1KCNQ3KCNQ2KCNQ4KCNQ5
SCHEMBL15198495 0.64
SCHEMBL517632 0.63 ALOX5 (0.41) KMT2ALMNAEPHX1HPGDRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1954668-A2 HOMO- AND HETEROCYCLIC COMPOUNDS SUITABLE AS CETP INHIBITORS Brystol-Myers Squibb Company (US) 2008-08-13 EP disclosed
WO-2007062308-A2 HOMO- AND HETEROCYCLIC COMPOUNDS SUITABLE AS CETP INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-05-31 WO disclosed